Latest news

U.S. Food and Drug Administration accepts the submitted Biologic License Application for Coagulation Factor VIIa (Recombinant), activated eptacog beta.

Read More

Contact Medical Affairs

Healthcare professionals, learn more about the science behind HEMA Biologics investigational treatments for the rarest bleeding disorders.

Read More

Join the brigade!

Check out our new app, and become Sergeant Factor in this exciting interactive experience.

Read More

“We aspire to support patients living with these disorders, partner with the broader community that cares for them, and bring meaningful treatments and services to help better their daily lives.”